NEURO2022

Session information

Poster

[2P] B. Development, Regeneration and Plasticity

Fri. Jul 1, 2022 11:00 AM - 12:00 PM Poster Session Hall 2 (Ginowan City Gymnasium)

*Koki Harada1, Takeshi Kato1, Masahiro Hirao1, Kaneyasu Nishimura1, Shun Shimohama2,3,4, Kazuyuki Takata1 (1. Div. Integ. Pharm. Sci., Kyoto Pharm. Univ., Kyoto, Japan, 2. Dept. Neurol., Sapporo Med. Univ. Sch. of Med., Sapporo, Japan, 3. Jiseikai Dementia Ctr., Tokyo, Japan, 4. Jiseikai Mem. Hosp., Tokyo, Japan)

*Naoto Ohte1,2, Pei-Shan Hou2,4,5, Chihiro Nishiyama4, Carina Hanashima1,2,3,4 (1. Faculty of Education, Department of Science, Waseda University, Tokyo, Japan, 2. Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan, 3. Faculty of Education and Integrated Arts and Sciences, Waseda University, Tokyo, Japan, 4. Laboratory for Neocortical Development, RIKEN Center for Developmental Biology, Kobe, Japan, 5. National Yang Ming Chiao Tung University Institute of Anatomy and Cell Biology, Taipei, Taiwan)

*Nobuyuki Sakayori1, Kazuki Fujii2, Masanori Katakura3, Kazuto Kobayashi4, Keizo Takao2, Makoto Sugita1 (1. Grad Sch Biomed Health Sci, Hiroshima University, Hiroshima, Japan, 2. Fac Med, Univ Toyama, Toyama, Japan, 3. Fac Pharmacy Pharmaceutical Sci, Josai Univ, Saitama, Japan, 4. Inst Biomed Sci, Fukushima Med Univ, Fukushima, Japan)

*Rika Sakuma1, Miku Kobayashi2, Rui Kobashi2, Mako Onishi2, Mitsuyo Maeda3,4, Yosky Kataoka3,4, Susumu Imaoka2 (1. Department of Anatomy and Cell Biology, Hyogo College of Medicine, 2. Sch of Biol and Environmental Sci, Kwansei Gakuin Univ, Hyogo, Japan, 3. Multi-Modal Microstructure Analysis Unit, RIKEN-JEOL Collaboration Center, Hyogo, Japan, 4. Laboratory for Cellular Function Imaging, RIKEN Center for Biosystems Dynamics Research)

*Hideaki Nishie1,4, Akiko Nakano-Doi1,2, Toshinori Sawano3, Takayuki Nakagomi1,2 (1. Institute for Advanced Medical Sciences, Hyogo College of Medicine, 2. Department of Therapeutic Progress in Brain Diseases, Hyogo College of Medicine, 3. Department of Biomedical Sciences, Ritsumeikan University, 4. Nippon Zoki Pharmaceutical Co., Ltd.)

*Yusuke Minato1, Akiko Nakano-Doi2, Sachi Kuwahara-Otani3, Seishi Maeda1, Tomohiro Matsuyama4, Takayuki Nakagomi2, Hideshi Yagi1 (1. Dept Anat and Cell Biol, Hyogo Col of Med, Hyogo, Japan, 2. Inst Adv Med Sci, Hyogo Col of Med, Hyogo, Japan, 3. Gen Edu Ctr, Hyogo Univ of Health Sci, Hyogo, Japan, 4. Dept Therap Progress in Brain Deiseases, Hyogo Col of Med, Hyogo, Japan)

*Aoi Nonoyama1,2, Miho Kawata2, Yu Kodani2, Toshiki Kameyama2, Kanako Saito2, Hidetaka Suga3, Hiroshi Nagasaki2 (1. Grad Sch Med, Fujita Health University, Aichi, Japan, 2. Department of Physiology, School of Medicine, Fujita Health University, Aichi, Japan, 3. Department of Endocrinology and Diabetes, Grad Sch Med, Nagoya University, Aichi, Japan)

*Madhura Subba Rao1,2, Hiromi Mizuno1,2, Takuya Sato3, Takuji Iwasato3,4, Hidenobu Mizuno1,2 (1. Laboratory of Multi-dimensional Imaging, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto 860-0811, Japan, 2. Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-0811, Japan, 3. Laboratory of Mammalian Neural Circuits, National Institute of Genetics, Mishima 411-8540, Japan, 4. Department of Genetics, SOKENDAI, Mishima 411-8540, Japan)

*William Aoi Omi1,2, Kazutoshi Hisano2,3, Hironori Yoshida1,2, Shiori Kawase4, Tetsuhiko Mimura2,3, Fumiaki Makiyama2,3, Ryoya Nakada1,2, Hisao Haniu1,2,3, Tamotsu Tsukahara5, Taiga Kurihara6, Yoshikazu Matsuda7, Naoto Saito1,2,3, Takeshi Uemura1,2,3,4 (1. Grad. Sch. of. Sci. & Tech., Shinshu Univ., Nagano, Japan, 2. IBS-ICCER, Shinshu Univ, Nagano, Japan, 3. Grad. Sch. of. Med., Sci. & Tech., Shinshu Univ., Nagano, Japan, 4. Div. of Gene Res., Res. Cent. for Advanced Sci., Shinshu Univ, Nagano, Japan, 5. Dept. Pharmacol. Therap. Innov, Nagasaki Univ., Inst. Biomed. Sci., Nagasaki, Japan, 6. Div.Microbiol. & Mol. Cell. Biol. Nihon Pharmaceutical Univ, Saitama, Japan, 7. Div. Clinical Pharmacol., Nihon Pharmaceutical Univ, Saitama, Japan)

*Luwei Wang1,2, Shingo Nakazawa1,3, Hidenobu Mizuno4, Takuji Iwasato1,2 (1. Laboratory of Mammalian Neural Circuits, National Institute of Genetics, Mishima, 2. Department of Genetics, The Graduate University for Advanced Studies (SOKENDAI), Mishima, 3. Department of Basic Neurosciences, University of Geneva, Switzerland, 4. International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan)

*Adam T. Guy1,2, Mariko Inoue2, Yoshio Hirabayashi3,4, Kei Hanafusa4, Mitsuaki Yanagida4, Kazuhisa Iwabuchi4, Kei Yamamoto5, Makoto Murakami6, Hiroyuki Kamiguchi2,7 (1. Grad Sch of Biostudies, Kyoto University, Kyoto, Japan, 2. Neural Cell Dynamics Lab, RIKEN CBS, Wako, Japan, 3. Cellular Informatics Lab, RIKEN CPR, Wako, Japan, 4. Institute for Environmental and Gender-Specific Medicine, Grad Sch of Medicine, Juntendo University, Tokyo, Japan, 5. Grad Sch of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan, 6. Center for Disease Biology and Integrative Medicine, Grad Sch of Medicine, University of Tokyo, Tokyo, Japan, 7. AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan)

*Jun NOGUCHI1, Satoshi WATANABE1, Risa ISODA1, Keiko NAKAGAKI1, Kazuhisa SAKAI1, Eriko SUGANO2, Hiroshi TOMITA2, Akiya WATAKABE3, Tetsuo YAMAMORI3, Hiroaki MIZUKAMI4, Noritaka ICHINOHE1 (1. National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Grad Course Biol Sci, Iwate University, Iwate, Japan, 3. Center Brain Sci, RIKEN, Saitama, Japan, 4. Div Genet Therapeutics, Jichi Med Univ, Tochigi, Japan)

×

Authentication

×

Please log in with your participant account.
» Participant Log In